These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26427400)

  • 1. Challenges in the Development of Therapy for Dry Age-Related Macular Degeneration.
    Wei CX; Sun A; Yu Y; Liu Q; Tan YQ; Tachibana I; Zeng H; Wei JY
    Adv Exp Med Biol; 2016; 854():103-9. PubMed ID: 26427400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).
    Ramkumar HL; Zhang J; Chan CC
    Prog Retin Eye Res; 2010 May; 29(3):169-90. PubMed ID: 20206286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the development of glaucoma neuroprotection therapy.
    Liu Y; Pang IH
    Cell Tissue Res; 2013 Aug; 353(2):253-60. PubMed ID: 23474740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current therapeutic developments in atrophic age-related macular degeneration.
    Hanus J; Zhao F; Wang S
    Br J Ophthalmol; 2016 Jan; 100(1):122-7. PubMed ID: 26553922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dry Form of Age-Related Macular Degeneration (AMD): The Current Concepts of Pathogenesis and Prospects for Treatment.
    Zając-Pytrus HM; Pilecka A; Turno-Kręcicka A; Adamiec-Mroczek J; Misiuk-Hojło M
    Adv Clin Exp Med; 2015; 24(6):1099-104. PubMed ID: 26771984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Age-related Macular Degeneration in the Japanese].
    Yoshimura N
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Complement Regulatory Protein CD46 Deficient Mouse Spontaneously Develops Dry-Type Age-Related Macular Degeneration-Like Phenotype.
    Lyzogubov VV; Bora PS; Wu X; Horn LE; de Roque R; Rudolf XV; Atkinson JP; Bora NS
    Am J Pathol; 2016 Aug; 186(8):2088-2104. PubMed ID: 27295359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Clinical Trials in Dry Age-related Macular Degeneration.
    Taskintuna I; Elsayed ME; Schatz P
    Middle East Afr J Ophthalmol; 2016; 23(1):13-26. PubMed ID: 26957835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the management of dry age-related macular degeneration: A review.
    Bandello F; Sacconi R; Querques L; Corbelli E; Cicinelli MV; Querques G
    F1000Res; 2017; 6():245. PubMed ID: 28529701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
    Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
    JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RPE-Directed Gene Therapy Improves Mitochondrial Function in Murine Dry AMD Models.
    Millington-Ward S; Chadderton N; Finnegan LK; Post IJM; Carrigan M; Nixon R; Humphries MM; Humphries P; Kenna PF; Palfi A; Farrar GJ
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue engineering in age-related macular degeneration: a mini-review.
    Wu A; Lu R; Lee E
    J Biol Eng; 2022 May; 16(1):11. PubMed ID: 35578246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of age-related macular degeneration and therapeutic opportunities.
    van Lookeren Campagne M; LeCouter J; Yaspan BL; Ye W
    J Pathol; 2014 Jan; 232(2):151-64. PubMed ID: 24105633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of the RPE in AMD.
    Binder S; Stanzel BV; Krebs I; Glittenberg C
    Prog Retin Eye Res; 2007 Sep; 26(5):516-54. PubMed ID: 17532250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dry AMD - Cellular and Genetic Therapies].
    Johnen S; Koutsonas A
    Klin Monbl Augenheilkd; 2019 Sep; 236(9):1096-1102. PubMed ID: 31212338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hot Topics in Dry AMD.
    Narayanan R; Kuppermann BD
    Curr Pharm Des; 2017; 23(4):542-546. PubMed ID: 28003009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between polymorphisms of the DNA base excision repair genes MUTYH and hOGG1 and age-related macular degeneration.
    Synowiec E; Blasiak J; Zaras M; Szaflik J; Szaflik JP
    Exp Eye Res; 2012 May; 98():58-66. PubMed ID: 22469746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures.
    Yehoshua Z; Rosenfeld PJ; Albini TA
    Semin Ophthalmol; 2011 May; 26(3):167-80. PubMed ID: 21609230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drusen in Bruch's membrane. Their significance for the pathogenesis and therapy of age-associated macular degeneration].
    Pauleikhoff D
    Ophthalmologe; 1992 Oct; 89(5):363-86. PubMed ID: 1304217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.